Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.160
+0.020 (1.75%)
May 13, 2025, 4:00 PM - Market closed

Ikena Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-41.71-49.23-68.17-68.77-34.12-44.26
Upgrade
Depreciation & Amortization
0.360.491.020.750.540.3
Upgrade
Loss (Gain) From Sale of Assets
-0.840.010.17--
Upgrade
Asset Writedown & Restructuring Costs
--1.74--11.14
Upgrade
Loss (Gain) From Sale of Investments
-1.27-1.47-2.020.06--
Upgrade
Stock-Based Compensation
4.25.37.637.535.181.8
Upgrade
Other Operating Activities
2.142.051.711.281.170.96
Upgrade
Change in Accounts Payable
-1.1-1.17-2.87-0.290.360.52
Upgrade
Change in Unearned Revenue
---9.16-15.62-30.99-9.19
Upgrade
Change in Other Net Operating Assets
-0.88-2.81-9.640.77-2.410.9
Upgrade
Operating Cash Flow
-38.26-46-79.74-74.11-60.25-37.83
Upgrade
Capital Expenditures
---0.41-1.43-1.76-0.77
Upgrade
Sale of Property, Plant & Equipment
0.380.44----
Upgrade
Cash Acquisitions
-----3.69
Upgrade
Investment in Securities
28.89-27.8464.56-97.85--
Upgrade
Investing Cash Flow
21.77-34.964.14-99.28-1.762.92
Upgrade
Issuance of Common Stock
--37.561.1131.880.07
Upgrade
Repurchase of Common Stock
---0.66---
Upgrade
Other Financing Activities
--39.09---0.06
Upgrade
Financing Cash Flow
--75.981.1131.74116.18
Upgrade
Net Cash Flow
-16.5-80.9160.38-172.369.7381.28
Upgrade
Free Cash Flow
-38.26-46-80.16-75.54-62.01-38.59
Upgrade
Free Cash Flow Margin
---875.08%-483.67%-200.14%-419.75%
Upgrade
Free Cash Flow Per Share
-0.79-0.95-1.92-2.09-2.22-13.96
Upgrade
Levered Free Cash Flow
-25.47-31.55-47.98-41.98-21-23
Upgrade
Unlevered Free Cash Flow
-25.47-31.55-47.98-41.98-21-23
Upgrade
Change in Net Working Capital
0.963.249.084.513.63-3.49
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q